Glaser C B, Busby T F, Ingham K C, Childs A
Am Rev Respir Dis. 1983 Jul;128(1):77-81. doi: 10.1164/arrd.1983.128.1.77.
Alpha 1-protease inhibitor (alpha 1 PI), also called alpha 1-antitrypsin, may be useful for replacement therapy in a number of chronic or acute disorders. The risk associated with the possible presence of hepatitis virus can be greatly reduced by pasteurization at 60 degrees C for 10 h. A series of thermal denaturation profiles was obtained in the presence of various protein stabilizers using the increase in 1,8-anilinonaphthalene sulfonate fluorescence that accompanies protein denaturation. A parallel series of experiments was conducted to evaluate each additive for its capacity to protect the biological activity of alpha 1 PI. As much as 92% of the inhibitory activity against elastase and trypsin could be recovered after pasteurization in buffer containing citrate (1.2 M) and either EDTA (0.5 M) or gluconate (1.2 M). Loss of activity was not affected by protein concentration. In conclusion, conditions have been developed to protect the bulk of alpha 1 PI from denaturation during pasteurization, and this should give an added impetus to efforts to test the efficacy of this protein in various clinical conditions.
α1-蛋白酶抑制剂(α1-PI),也称为α1-抗胰蛋白酶,可能对多种慢性或急性疾病的替代治疗有用。通过在60摄氏度下进行10小时的巴氏杀菌,可大大降低与可能存在的肝炎病毒相关的风险。利用蛋白质变性时伴随的1,8-苯胺基萘磺酸盐荧光的增加,在各种蛋白质稳定剂存在的情况下获得了一系列热变性曲线。进行了一系列平行实验,以评估每种添加剂保护α1-PI生物活性的能力。在含有柠檬酸盐(1.2 M)以及EDTA(0.5 M)或葡萄糖酸盐(1.2 M)的缓冲液中进行巴氏杀菌后,对弹性蛋白酶和胰蛋白酶的抑制活性可恢复多达92%。活性丧失不受蛋白质浓度的影响。总之,已经开发出在巴氏杀菌过程中保护大部分α1-PI不发生变性的条件,这应该会为在各种临床条件下测试这种蛋白质的功效的努力增添动力。